Validated target selected by Aventis in osteoarthritis research collaboration with GPC Biotech Jan. 14, 2002
Phase IIa results of ABX-IL-8 in rheumatoid arthritis do not warrant progression to phase IIb trials Jan. 8, 2002
Potent new MMP inhibitor has excellent oral activity in a rat collagen degradation model Dec. 27, 2001
RSS